Nature, Published online: 21 September 2026; doi:10.1038/d41586-026-02981-9Technique uses chemical tags to shut down viral DNA lurking in host’s genome.
A new experimental therapy for hepatitis B is trying to do something different from existing treatments: not only to keep the virus under control, but to "definitely shut down its functioning mechanism in liver cells. Therapy has entered human testing.